CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 100 enrolled
Drug / intervention
Mitomycin-C +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02016898
NCT02016898Phase 2Completed
CompareCT.gov

The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device

Duke University·interventional·Posted Dec 20, 2013·Updated Feb 9, 2018

In Brief

A Phase 2 clinical trial evaluating Placement of the sponge and Mitomycin-C for Primary Open Angle Glaucoma. Completed, enrolled 100 participants across 1 site.

Detailed Summary

The primary focus of this study is to assess intraocular pressure and complication rates between patients who receive mitomycin-C using a sponge versus no-sponge.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPrimary Open Angle Glaucoma
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 20, 2013
Enrollment StartMar 1, 2014
Primary CompletionJan 17, 2017
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 12.5 years ago

Interventions

Placement of the spongeprocedure

Mitomycin-Cdrug